Publications by authors named "Nima Melzer"

Claim this Profile
T
The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.
Matthias Augustin, Dominik Beier, Jennifer Branner, Dennis Häckl, Regina Hampel, Nima Melzer

J Eur Acad Dermatol Venereol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study.
Lina Renkhold, Manuel P Pereira, Karin Loser, Dieter Metze, Daniel Baeumer, Nima Melzer

Acta Derm Venereol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation.
Ahmed H Seddik, Nima Melzer, Foteini Tsotra, Dennis A Ostwald

Pharmacoecon Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial.
Andreas Pinter, Peter Schwarz, Sascha Gerdes, Jan C Simon, Anja Saalbach, Nima Melzer

Nutrients· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients.
Peter E H Schwarz, Andreas Pinter, Nima Melzer, Philipp Barteczek, Maximilian Reinhardt

Dermatol Ther (Heidelb)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks.
Esther von Stebut, Kristian Reich, Diamant Thaçi, Wolfgang Koenig, Andreas Pinter, Nima Melzer

J Invest Dermatol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis.
Detlef H Krieter, Susanne Fink, Oliver Dorsch, Job Harenberg, Nima Melzer

Artif Organs· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin.
Hanno Riess, Lena K Becker, Nima Melzer, Job Harenberg

Blood Coagul Fibrinolysis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial.
Nima Melzer, Peter Bramlage, Hans-Christoph Michaelis

BMC Res Notes· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, non-interventional study on the real-world use of certoparin in daily practice--the PROMEMBER study.
Michael Spannagl, Nima Melzer, Peter Bramlage, Cornelia Englert, Ralf Eisele

Clin Appl Thromb Hemost· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging with the Low molecular weight heparin certoparin in patients requiring temporary discontinuation of oral anticoagulation - the non-interventional, retrospective REMEMBER study.
Ralf Eisele, Nima Melzer, Cornelia Englert, Peter Bramlage, Michael Spannagl

Thromb Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.
Sylvia K Haas, Mathias Freund, David Heigener, Lothar Heilmann, Bettina Kemkes-Matthes, Nima Melzer

Clin Appl Thromb Hemost· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement.
Peter Bramlage, Hans-Christoph Michaelis, Nima Melzer

Thromb J· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study.
Oliver Dorsch, Detlef H Krieter, Horst-Dieter Lemke, Stefan Fischer, Nima Melzer

BMC Nephrol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.
Sylvia Haas, Sebastian M Schellong, Ulrich Tebbe, Horst-Eberhard Gerlach, Rupert Bauersachs, Nima Melzer

BMC Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.
Nima Melzer, Carmen Villmann, Kristina Becker, Kirsten Harvey, Robert J Harvey

J Biol Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of disulfide bonds within the amino-terminal extracellular domain of the inhibitory glycine receptor.
Nicolas Vogel, Christoph J Kluck, Nima Melzer, Stephan Schwarzinger, Ulrike Breitinger

J Biol Chem· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recessive hyperekplexia mutations of the glycine receptor alpha1 subunit affect cell surface integration and stability.
Carmen Villmann, Jana Oertel, Nima Melzer, Cord-Michael Becker

J Neurochem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel regulatory site within the TM3-4 loop of human recombinant alpha3 glycine receptors determines channel gating and domain structure.
Hans-Georg Breitinger, Carmen Villmann, Nima Melzer, Janine Rennert, Ulrike Breitinger

J Biol Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis